microdosing glp 1 peptides GLP-1s: A complete guide to risks, benefits, and protocols What Is Microdosing GLP-1s, and

10.1016/j.devcel.2010.01.016 9 HongJ.ZhangM.HeY.JinY.HeQ.ZhangY.et al (2022)

Some patients experience mild side effects like nausea, digestive discomfort, or fatigue, which usually resolve over time

While even extremely high doses of GHK-Cu are unlikely to cause any adverse reactions, Pickart has estimated that the peptide can produce toxic action and start lowering a subjects blood pressure starting from an astronomical dose of about 22,500mg [13]

The histologic stages preceding transformation to melanoma are unknown

Studies have found GLP-1 receptors in the kidney itself.3 The protective effects include: reducing inflammation in kidney tissue, lowering blood pressure (by about 5-7 mmHg), improving how kidneys filter blood, and reducing protein leakage into urine an early warning sign of kidney damage.4 THE BIGGER PICTURE: 85,000+ PATIENTS A major meta-analysis of 11 clinical trials with 85,373 patients confirmed the kidney benefits